Rates and risks for late referral to hospice in patients with primary malignant brain tumors

Neuro-Oncology

Volumn 18, Issue 1, 2016, Pages 78-86

  Diamond, Eli L ^a,b   Russell, David ^c   Kryza Lacombe, Maria ^a   Bowles, Kathryn H ^c,d   Applebaum, Allison J ^a   Dennis, Jeanne ^c   Deangelis, Lisa M ^a   Prigerson, Holly G ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c VISITING NURSE SERVICE OF NEW YORK   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

glioblastoma; malignant brain tumor; palliative care; quality of life

Indexed keywords

ADULT; AGED; APHASIA; ARTICLE; BRAIN CANCER; COHORT ANALYSIS; DEATH; DYSPNEA; FEMALE; HOSPICE; HOSPICE CARE; HUMAN; IMMOBILITY; MAJOR CLINICAL STUDY; MALE; MEDICAID; PATIENT REFERRAL; PRIMARY MALIGNANT BRAIN TUMOR; PROXY; RETROSPECTIVE STUDY; RISK FACTOR; BRAIN TUMOR; HOME CARE; MIDDLE AGED; NURSING; UTILIZATION;

AGED; BRAIN NEOPLASMS; COHORT STUDIES; FEMALE; HOME CARE SERVICES; HOSPICE CARE; HUMANS; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84960364744     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nov156     Document Type: Article

References (50)

1. Amano K, Morita T, Tatara R, Katayama H, Uno T, Takagi I. Association between early palliative care referrals, inpatient hospice utilization, and aggressiveness of care at the end of life. J Palliat Med. 2015;18(3):270-273.
2. Bergman J, Saigal CS, Lorenz KA, et al. Hospice use and high-intensity care in men dying of prostate cancer. Arch Intern Med. 2011;171(3):204-210.
3. Wright AA, Zhang B, Ray A, et al. Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment. JAMA. 2008;300(14): 1665-1673.
4. Cheng SY, Dy S, Hu WY, Chen CY, Chiu TY. Factors affecting the improvement of quality of dying of terminally ill patients with cancer through palliative care: a ten-year experience. J Palliat Med. 2012;15(8):854-862.
5. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733-742.
6. Greer JA, Pirl WF, Jackson VA, et al. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol. 2012;30(4): 394-400.
7. McCarthy EP, Burns RB, Davis RB, Phillips RS. Barriers to hospice care among older patients dying with lung and colorectal cancer. J Clin Oncol. 2003;21(4):728-735.
8. Tang ST, Huang EW, Liu TW, Wang HM, Rau KM, Chen JS. Aggressive end-of-life care significantly influenced propensity for hospice enrollment within the last three days of life for Taiwanese cancer decedents. J Pain Symptom Manage. 2011;41(1):68-78.
9. Aldridge MD, Canavan M, Cherlin E, Bradley EH. Has Hospice Use Changed?. 2000-2010 Utilization Patterns. Med Care. 2015;53(1): 95-101.
10. Sizoo EM, Taphoorn MJ, Uitdehaag B, et al. The end-of-life phase of high-grade glioma patients: dying with dignity?. Oncologist. 2013; 18(2):198-203.
11. Koekkoek JA, Dirven L, Sizoo EM, et al. Symptoms and medication management in the end of life phase of high-grade glioma patients. J Neurooncol. 2014;120(3):589-595.
12. Sizoo EM, Braam L, Postma TJ, et al. Symptoms and problems in the end-of-life phase of high-grade glioma patients. Neuro Oncol. 2010;12(11):1162-1166.
13. Gofton TE, Graber J, Carver A. Identifying the palliative care needs of patients living with cerebral tumors and metastases: a retrospective analysis. J Neurooncol. 2012;108(3):527-534.
14. Pace A, Di Lorenzo C, Guariglia L, Jandolo B, Carapella CM, Pompili A. End of life issues in brain tumor patients. J Neurooncol. 2009; 91(1):39-43.
15. Walbert T, Khan M. End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review. J Neurooncol. 2014;117(2):217-224.
16. Finocchiaro CY, Petruzzi A, Lamperti E, et al. The burden of brain tumor: a single-institution study on psychological patterns in caregivers. J Neurooncol. 2012;107(1):175-181.
17. McConigley R, Halkett G, Lobb E, Nowak A. Caring for someone with high-grade glioma: a time of rapid change for caregivers. Palliat Med. 2010;24(5):473-479.
18. Pompili A, Telera S, Villani V, Pace A. Home palliative care and end of life issues in glioblastoma multiforme: results and comments from a homogeneous cohort of patients. Neurosurg Focus. 2014; 37(6):E5.
19. Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative performance scale (PPS): a new tool. J Palliat Care. Spring 1996; 12(1):5-11.
20. Myers J, Kim A, Flanagan J, Selby D. Palliative performance scale and survival among outpatients with advanced cancer. Support Care Cancer. 2015;23(4):913-918.
21. Enzinger AC, Zhang B, Weeks JC, Prigerson HG. Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death. J Pain Symptom Manage. 2014;47(6):1078-1090.
22. Wright AA, Mack JW, Kritek PA, et al. Influence of patients? preferences and treatment site on cancer patients? end-of-life care. Cancer. 2010;116(19):4656-4663.
23. The R Project for Statistical Computing (http://www.r-project.org).
24. Sizoo EM, Pasman HR, Dirven L, et al. The end-of-life phase of high-grade glioma patients: a systematic review. Support Care Cancer. 2014;22(3):847-857.
25. Diaz JL, Barreto P, Gallego JM, Barbero J, Bayes R, Barcia JA. Proper information during the surgical decision-making process lowers the anxiety of patients with high-grade gliomas. Acta Neurochir (Wien). 2009;151(4):357-362.
26. Ford E, Catt S, Chalmers A, Fallowfield L. Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro Oncol. 2012;14(4):392-404.
27. Diamond EL, Corner GW, De Rosa A, Breitbart W, Applebaum AJ. Prognostic awareness and communication of prognostic information in malignant glioma: a systematic review. J Neurooncol. 2014;119(2):227-234.
28. Weeks JC, Catalano PJ, Cronin A, et al. Patients? expectations about effects of chemotherapy for advanced cancer. N Engl J Med. 2012;367(17):1616-1625.
29. O?Connor NR, Hu R, Harris PS, Ache K, Casarett DJ. Hospice admissions for cancer in the final days of life: independent predictors and implications for quality measures. J Clin Oncol. 2014;32(28):3184-3189.
30. Earle CC, Landrum MB, Souza JM, Neville BA, Weeks JC, Ayanian JZ. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?. J Clin Oncol. 2008;26(23):3860-3866.
31. Haas JS, Earle CC, Orav JE, et al. Lower use of hospice by cancer patients who live in minority versus white areas. J Gen Intern Med. 2007;22(3):396-399.
32. Hardy D, Chan W, Liu CC, et al. Racial disparities in the use of hospice services according to geographic residence and socioeconomic status in an elderly cohort with nonsmall cell lung cancer. Cancer. 2011;117(7):1506-1515.
33. Nayar P, Qiu F, Watanabe-Galloway S, et al. Disparities in end of life care for elderly lung cancer patients. J Community Health. 2014; 39(5):1012-1019.
34. Fairfield KM, Murray KM, Wierman HR, et al. Disparities in hospice care among older women dying with ovarian cancer. Gynecol Oncol. 2012;125(1):14-18.
35. Mack JW, Chen K, Boscoe FP, et al. Underuse of hospice care by Medicaid-insured patients with stage IV lung cancer in New York and California. J Clin Oncol. 2013;31(20):2569-2579.
36. Loberiza Jr. F.R., Swore-Fletcher BA, Block SD, et al. Coping styles, health status and advance care planning in patients with hematologic malignancies. Leuk Lymphoma. 2011;52(12): 2342-2348.
37. Halpern NA, Pastores SM, Chou JF, Chawla S, Thaler HT. Advance directives in an oncologic intensive care unit: a contemporary analysis of their frequency, type, and impact. J Palliat Med. 2011; 14(4):483-489.
38. Gao X, PrigersonHG, DiamondEL, et al.Minorcognitive impairments in cancer patients magnify the effect of caregiver preferences on end-of-life care. J Pain Symptom Manage. 2013;45(4):650-659.
39. Goutman SA, Nowacek DG, Burke JF, Kerber KA, Skolarus LE, Callaghan BC. Minorities, men, and unmarried amyotrophic lateral sclerosis patients are more likely to die in an acute care facility. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(5-6):440-443.
40. du Preez AE, Smith MA, Liou JI, et al. Predictors of hospice utilization among acute stroke patients who died within thirty days. J Palliat Med. 2008;11(9):1249-1257.
41. Karikari-Martin P, McCann JJ, Hebert LE, Haffer SC, Phillips M. Do Community and Caregiver Factors Influence Hospice Use at the End of Life Among Older Adults With Alzheimer Disease?. J Hosp Palliat Nurs. 2012;14(3):225-237.
42. Loggers ET, Maciejewski PK, Paulk E, et al. Racial differences in predictors of intensive end-of-life care in patients with advanced cancer. J Clin Oncol. 2009;27(33):5559-5564.
43. Smith AK, McCarthy EP, Paulk E, et al. Racial and ethnic differences in advance care planning among patients with cancer: impact of terminal illness acknowledgment, religiousness, and treatment preferences. J Clin Oncol. 2008;26(25):4131-4137.
44. Johnson KS, Kuchibhatla M, Tulsky JA. What explains racial differences in the use of advance directives and attitudes toward hospice care?. J Am Geriatr Soc. 2008;56(10):1953-1958.
45. Sizoo EM, Pasman HR, Buttolo J, et al. Decision-making in the end-of-life phase of high-grade glioma patients. Eur J Cancer. 2012;48(2):226-232.
46. Triebel KL, Martin RC, Nabors LB, Marson DC. Medical decision-making capacity in patients with malignant glioma. Neurology. 2009;73(24):2086-2092.
47. Gerstenecker A, Meneses K, Duff K, Fiveash JB, Marson DC, Triebel KL. Cognitive predictors of understanding treatment decisions in patients with newly diagnosed brain metastasis. Cancer. 2015; 121(12):2013-2019.
48. Phelps AC, Maciejewski PK, Nilsson M, et al. Religious coping and use of intensive life-prolonging care near death in patients with advanced cancer. JAMA. 2009;301(11):1140-1147.
49. Balboni TA, Vanderwerker LC, Block SD, et al. Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life. J Clin Oncol. 2007;25(5):555-560.
50. True G, Phipps EJ, Braitman LE, Harralson T, Harris D, Tester W. Treatment preferences and advance care planning at end of life: the role of ethnicity and spiritual coping in cancer patients. Ann Behav Med. 2005;30(2):174-179.